Skip to main content
. 2016 Oct 25;41(3):287–296. doi: 10.5114/ceji.2016.63129

Table 3.

Number of patients with acute graft versus host disease (aGvHD) with or without CMV/EBV reactivation

aGvHD status CMV/EBV reactivation Without CMV/EBV reactivation Total aGvHD
aGvHD grade 0-I (%) 30 (35) 27 (31) 57 (66)
aGvHD grade II-IV (%) 22 (26) 7 (8) 29 (34)
Total with or without reactivation (%) 52 (60) 34 (40) 86 (100)

χ2 Pearson test, p = 0.03725, OR = 2.82, RR = 2.06